D012899

2 trials

Sponsors

Mugen Ujiie, Ujiie Mugen

Conditions

Monkeypox Monkeypox

Phase 1

A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adults

Active, not recruitingJPRN-jRCTs031220171

Ujiie MugenMonkeypox Monkeypox

Start: 2022-07-04Target: 50Updated: 2025-07-18

Phase 2

Smallpox vaccine trial as post-exposure prophylaxis in monkeypox

Active, not recruitingJPRN-jRCTs031220137

Mugen UjiieMonkeypox Monkeypox

Start: 2022-07-28Target: 150Updated: 2025-07-18

Related Papers

Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults

NEJM Evidence2024-02-2728 citations

Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study

JMIR Research Protocols2023-08-255 citations